Cancer Care: Chart Set www.oecd.org/health/health-systems/cancer-care.htm
110 123 129 120 130 146 143 138 144 164 167 163 156 163 162 166 156 149 172 172 175 166 167 179 182 173 138 187 189 178 192 186 176 198 193 208 219 201 230 227 219 240 238 263 261 251 262 279 275 271 261 259 262 258 261 257 290 282 278 270 275 300 290 299 292 317 321 336 371 360 362 405 All cancer mortality rates, total and by gender, 2011 (or nearest year) 450 Age-standardised rates per 100 000 population Wo men Men Total 400 350 300 250 200 150 100 50 0 Source: OECD Health Statistics 2013 (extracted from WHO), http://dx.doi.org/10.1787/health-data-en.
-28.4-27.0-25.3-22.6-22.2-21.9-20.7-20.4-20.2-20.2-20.1-19.4-18.0-17.4-16.9-16.6-16.1-16.0-15.0-14.4-13.4-12.7-12.1-12.1-11.5-10.8-9.9-9.6-6.2-5.6-3.8-3.6-2.5 0.4 3.4 6.0 11.5 Change in % over the period 20 Change in all cancer mortality rates, 1990-2011 (or nearest year) 10 0-10 -20-30 -40 Source: OECD Health Statistics 2013 (extracted from WHO), http://dx.doi.org/10.1787/health-data-en.
Mammography screening in women aged 50-69, 2001 to 2011 (or nearest year) Finland ¹ Netherlands ¹ United States ² Austria ² Spain ² Denmark ¹ Portugal ² Israel ¹ Slovenia ¹ United Kingdom ¹ Norway ¹ Ireland ¹ Canada ² New Zealand ¹ OECD20 Belgium ¹ Luxembourg ¹* Iceland ¹* Italy ¹ Korea ¹ Poland ² Australia ¹ Germany ¹ France ¹ Czech Rep. ¹ Estonia ¹ Greece ² Hungary ¹ Switzerland ² Japan 2 Turkey ¹ Mexico ¹ Slovak Rep. ¹ Chile ¹ 87.4 80.4 84.8 75.3 77.6 76.3 72.7 62.6 53.3 50.0 55.8 61.7 59.0 9.3 24.8 56.9 38.1 25.7 37.0 22.5 9.1 2011 2001 1. Programme. 2. Survey. * Three-year average. Source: OECD Health Statistics 2013, http://dx.doi.org/10.1787/health-data-en. 85.5 82.1 80.4 80.2 77.1 73.7 73.6 72.9 72.8 72.6 72.6 72.2 72.2 71.0 61.5 61.0 60.2 59.7 59.6 58.9 57.1 55.0 54.3 53.5 52.7 51.0 49.5 47.4 44.8 36.4 27.3 17.4 16.0 9.4 0 25 50 75 100 % of w omen screened
Breast cancer five-year relative survival, 2001-2006 and 2006-2011 (or nearest period) United States ² Canada ² Australia ¹ Iceland ²* Japan ² New Zealand ¹ Sweden ² Israel ¹ Norway ¹ Netherlands ² Finland ¹ Slovenia ¹ Korea ¹ Germany ¹ Belgium ¹ Singapore ² Austria ² OECD (19) Portugal ² Denmark ² United Kingdom ¹ Latvia ² Czech Rep. ² Ireland ¹ Poland ² 2006-2011 2001-2006 0.0 87.5 86.5 87.0 87.3 84.4 85.7 86.1 83.7 84.9 84.7 83.1 82.6 0.0 84.8 78.6 81.8 82.6 82.3 81.8 78.6 76.5 76.4 77.3 70.2 1. Period analysis. 2. Cohort analysis. * Three-period average. Note: 95% confidence intervals represented by H. Source: OECD Health Statistics 2013, http://dx.doi.org/10.1787/health-data-en. 73.6 84.2 82.6 82.0 80.7 80.7 80.7 80.5 87.7 87.7 87.4 86.4 86.2 86.1 85.9 85.9 85.6 85.2 85.0 85.0 84.6 84.5 89.3 0 20 40 60 80 100 Age-standardised survival (%)
6.2 12.7 13.7 17.8 20.1 25.3 29.5 23.0 28.1 27.7 26.7 25.5 29.6 28.1 32.2 30.2 33.8 32.6 31.6 31.3 27.0 31.2 28.3 31.4 31.8 33.3 37.7 34.6 25.6 34.1 38.2 35.0 40.8 38.5 40.6 35.8 43.6 7.8 14.2 14.5 19.4 20.3 21.2 21.5 22.5 22.8 23.1 23.2 24.2 24.5 24.8 26.0 26.3 26.5 26.6 27.1 27.1 27.2 27.5 27.7 28.3 28.8 30.0 30.4 30.7 30.9 31.2 31.2 31.5 31.6 32.3 32.8 34.2 34.7 Breast cancer mortality in women, 2001 to 2011 (or nearest year) Age-standardised rates per 100 000 w omen 2001 2011 45 40 35 30 25 20 15 10 5 0 * Three-year average. Source: OECD Health Statistics 2013, http://dx.doi.org/10.1787/health-data-en.
Cervical cancer screening in women aged 20-69, 2001 to 2011 (or nearest year) United States ² Austria ² Germany ² Sweden ¹ Norway ¹ New Zealand ¹ Switzerland ² Canada ² Slovenia ¹ France ² Finland ¹ Greece ² Poland ² United Kingdom ¹ Spain ² Denmark ¹ Netherlands ¹ Iceland ¹* Ireland ¹ Belgium ¹ OECD24 Chile ¹ Australia ¹ Portugal ² Estonia ¹ Czech Rep. ¹ Korea ¹ Luxembourg ¹* Italy ¹ Japan ² Hungary ¹ Slovak Rep. ¹ Mexico ¹ Turkey ¹ 89.5 78.4 80.1 72.7 76.5 74.1 67.1 76.3 70.3 49.0 81.5 65.7 74.0 59.5 56.7 65.0 61.1 33.3 11.7 36.5 37.7 22.6 40.2 23.2 13.7 22.9 20.0 15.5 2011 2001 1. Programme. 2. Survey. * Three-year average. Source: OECD Health Statistics 2013, http://dx.doi.org/10.1787/health-data-en. 85.0 81.5 78.7 78.4 76.2 75.0 74.9 73.4 72.2 71.1 69.8 69.7 73.0 68.5 67.7 66.3 66.1 65.0 64.9 63.2 59.6 59.5 56.8 54.8 53.0 51.5 48.4 47.5 41.2 37.7 36.9 0 25 50 75 100 % of w omen screened
Cervical cancer five-year relative survival, 2001-2006 and 2006-2011 (or nearest period) Korea ¹ Norway ¹ Israel ¹ Japan ² Austria ² Iceland ²* Sweden ² Australia ¹ Netherlands ² Denmark ² OECD (19) Canada ² Belgium ¹ Slovenia ¹ Finland ¹ Czech Rep. ² New Zealand ¹ Germany ¹ United States ² Portugal ² United Kingdom ¹ Singapore ² Latvia ² Ireland ¹ Poland ² 2006-2011 2001-2006 76.6 65.5 67.0 70.2 64.5 57.4 66.0 67.0 68.5 69.3 64.8 71.7 64.9 66.7 65.4 61.6 66.4 0.0 0.0 62.0 60.2 69.3 59.6 58.7 51.5 1. Period analysis. 2. Cohort analysis. * Three-period average. 52.7 58.0 57.2 Note: 95% confidence intervals represented by H. Source: OECD Health Statistics 2013, http://dx.doi.org/10.1787/health-data-en. 64.1 60.7 60.6 67.5 66.5 66.4 66.0 66.0 66.0 65.6 65.1 64.9 64.7 64.5 64.4 71.4 71.4 69.5 68.4 76.8 0 25 50 75 100 Age-standardised survival (%)
1.1 2.0 2.1 2.7 2.9 2.6 2.8 2.3 3.5 4.9 2.3 2.4 2.4 2.9 1.3 4.1 2.9 3.6 2.7 3.6 2.7 3.1 4.5 4.5 4.8 4.7 3.9 7.0 9.1 7.6 8.0 7.8 9.3 7.2 12.3 17.8 1.0 1.3 1.4 1.2 2.0 2.0 2.0 2.1 2.1 2.3 2.3 2.1 2.4 2.4 2.5 2.5 2.5 2.7 2.9 3.0 3.1 3.2 3.4 3.7 3.7 4.2 4.3 5.1 6.7 7.1 7.1 7.4 7.5 8.6 9.6 11.4 Cervical cancer mortality, 2001 to 2011 (or nearest year) Age-standardised rates per 100 000 w omen 18 2001 2011 16 14 12 10 8 6 4 2 0 * Three-year average. Source: OECD Health Statistics 2013, http://dx.doi.org/10.1787/health-data-en.
Colorectal cancer, five-year relative survival, 2001-06 and 2006-11 (or nearest period) Korea ¹ Japan ² Israel ¹ Australia ¹ United States ² Belgium ¹ Germany ¹ Finland ¹ Canada ² New Zealand ¹ Sweden ² Norway ¹ Netherlands ² Austria ² Slovenia ¹ OECD (18) Singapore ² Ireland ¹ Portugal ² Denmark ² United Kingdom ¹ Czech Rep. ² Latvia ² Poland ² 2006-2011 2001-2006 64.6 72.8 68.0 65.0 67.1 63.7 66.2 64.5 63.5 64.5 64.3 61.3 63.8 63.0 63.5 62.3 63.4 59.6 63.1 59.6 62.9 58.9 62.9 59.5 62.6 60.4 62.5 58.0 61.3 56.5 59.2 53.5 58.6 55.0 58.3 51.4 55.5 51.6 54.0 48.2 53.4 45.0 49.1 42.5 47.7 0 20 40 60 80 Age-standardised survival (%) 1. Period analysis, 2. Cohort analysis. Note: 95% confidence intervals represented by H. Source: OECD Health Statistics 2013, http://dx.doi.org/10.1787/health-data-en.
Colorectal cancer, five-year relative survival by gender, 2006-11 (or nearest period) Korea ¹ Japan ² Israel ¹ Iceland ²* Australia ¹ United States ² Germany ¹ Belgium ¹ Netherlands ² Austria ² Canada ² New Zealand ¹ Sweden ² Norway ¹ OECD22 Finland ¹ Slovenia ¹ Ireland ¹ Portugal ² United Kingdom ¹ Denmark ² Czech Rep. ² Poland ² Men Women 74.3 71.2 69.2 66.9 68.5 68.4 67.2 68.2 65.0 67.7 64.4 64.8 63.4 65.5 63.1 66.0 63.0 62.8 62.8 62.6 62.4 64.7 62.3 64.7 61.8 64.4 61.8 63.9 61.3 63.3 61.0 66.7 58.9 67.2 57.6 59.7 56.8 60.3 53.2 55.0 52.9 58.9 52.5 54.9 46.9 48.8 0 20 40 60 80 Age-standardised survival (%) 1. Period analysis, 2. Cohort analysis. * Three-period average. 95% confidence intervals represented by H. Source: OECD Health Statistics 2013, http://dx.doi.org/10.1787/health-data-en.
6.6 10.6 13.8 15.5 17.6 19.2 23.3 28.7 22.4 25.2 17.9 29.5 24.9 25.6 26.1 25.3 25.1 25.5 31.2 25.4 28.3 32.3 31.9 28.4 27.9 27.1 28.8 29.5 27.6 29.9 35.7 38.2 37.6 46.9 33.0 42.1 48.9 7.1 12.8 12.8 16.9 17.0 17.5 17.6 19.0 19.1 20.5 20.9 21.8 22.6 22.9 22.9 23.0 23.5 23.6 24.0 24.2 25.0 25.2 25.8 25.8 27.7 28.1 28.2 28.5 28.7 28.7 29.6 31.0 32.5 33.0 34.7 37.2 45.2 Colorectal cancer mortality, 2001 to 2011 (or nearest year) Age-standardised rates per 100 000 population 2001 2011 50 45 40 35 30 25 20 15 10 5 0 * Three-year average. Source: OECD Health Statistics 2013, http://dx.doi.org/10.1787/health-data-en.
Cervical cancer screening in past 3 years by income level, selected OECD countries, 2009 (or nearest year) Low income Average High income United States Austria Spain Slovenia Canada New Zealand France Poland Denmark Belgium Czech Republic Hungary Slovak Republic United Kingdom Mexico 1 Estonia 0 20 40 60 80 100 % of w omen aged 20-69 1. Visits in the past 12 months. Source: Devaux and de Looper (2012).
Breast cancer screening in past 2 years by income level, selected OECD countries, 2009 (or nearest year) Low income Average High income Spain Austria United States France New Zealand Canada Belgium Czech Republic Hungary Poland Slovak Republic United Kingdom Slovenia Estonia Mexico 1 Denmark 1 0 20 40 60 80 100 % of w omen aged 50-69 1. Visits in the past 12 months. Source: Devaux and de Looper (2012).
Colorectal cancer screening once in lifetime by educational level, European countries, 2009 (or nearest year) % of people aged 50-75 60 Lowest educational level Medium educational level Highest educational level 50 40 30 20 10 0 Source: Eurostat Statistics Database 2013.
More information www.oecd.org/health/health-systems/cancer-care.htm www.oecd.org/health/healthataglance www.oecd.org/els/health-systems/oecdhealthdata.htm